Abstract
There is growing evidence for a graft-versus-myeloma effect following allogeneic stem cell transplantation. We add to this evidence by reporting complete remission achieved by withdrawal of immunosuppression in a patient with multiple myeloma progressing after HLA-identical sibling peripheral stem cell transplantation. De novo chronic graft-versus-host disease coincided with the anti-myeloma effect and responded to treatment. The patient remains in complete remission 3 years after transplant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Libura, J., Hoffmann, T., Passweg, J. et al. Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 24, 925–927 (1999). https://doi.org/10.1038/sj.bmt.1701980
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701980
Keywords
This article is cited by
-
Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity
Bone Marrow Transplantation (2016)
-
Allogeneic stem cell transplantation for multiple myeloma: is there a future?
Bone Marrow Transplantation (2016)
-
The allogeneic dilemma
Bone Marrow Transplantation (2007)
-
The current status of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
Leukemia (2006)
-
Parameters for predicting allogeneic PBSCT outcome of acute myeloid leukemia: cytogenetics at presentation versus disease status at transplantation
Annals of Hematology (2005)